Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayu Takeda

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Dementia and Geriatric Cognitive Disorders Extra|January 2, 2013
No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's DiseaseTohru Ohnuma, Tohru Nakamura, Yuto Takebayashi, et al.
Oncology Research|June 3, 2026
Identification of <i>BRCA2</i> Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung AdenocarcinomasDat Quoc Tran, Mayu Takeda, Eiji Sugihara, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Relationship Between Oral Function and Social Participation Among Community-Dwelling Older Adults: An Observational Cross-Sectional StudyMayu Takeda, Yuhei Matsuda, Takafumi Abe, et al.
Experimental Hematology|March 20, 2013
Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2Misaki Kawasoe, Yasuko Yamamoto, Katsuya Okawa, et al.
Clinical Neurology and Neurosurgery|March 6, 2026
Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective seriesDaijiro Kojima, Shigeo Ohba, Yuya Nishiyama, et al.
Schizophrenia Bulletin|January 23, 2014
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophreniaNarimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 26, 2017
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophreniaShohei Nishimon, Tohru Ohnuma, Yuto Takebayashi, et al.
Pathology International|April 9, 2026
Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E-Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 CasesSeiji Yamada, Tetsuya Takimoto, Mina Ikeda, et al.
Cancer Science|January 17, 2025
Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical ImplicationsYuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 11, 2017
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophreniaTakahiro Sannohe, Tohru Ohnuma, Masayoshi Takeuchi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Dementia and Geriatric Cognitive Disorders Extra|January 2, 2013
No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's DiseaseTohru Ohnuma, Tohru Nakamura, Yuto Takebayashi, et al.
Oncology Research|June 3, 2026
Identification of <i>BRCA2</i> Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung AdenocarcinomasDat Quoc Tran, Mayu Takeda, Eiji Sugihara, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Relationship Between Oral Function and Social Participation Among Community-Dwelling Older Adults: An Observational Cross-Sectional StudyMayu Takeda, Yuhei Matsuda, Takafumi Abe, et al.
Experimental Hematology|March 20, 2013
Acquired resistance of leukemic cells to AraC is associated with the upregulation of aldehyde dehydrogenase 1 family member A2Misaki Kawasoe, Yasuko Yamamoto, Katsuya Okawa, et al.
Clinical Neurology and Neurosurgery|March 6, 2026
Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective seriesDaijiro Kojima, Shigeo Ohba, Yuya Nishiyama, et al.
Schizophrenia Bulletin|January 23, 2014
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophreniaNarimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 26, 2017
High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophreniaShohei Nishimon, Tohru Ohnuma, Yuto Takebayashi, et al.
Pathology International|April 9, 2026
Genomic Alteration Patterns Across Histological Grades in BRAF p.V600E-Mutant Gliomas and Glioneuronal Tumors: An Analysis of 15 CasesSeiji Yamada, Tetsuya Takimoto, Mina Ikeda, et al.
Cancer Science|January 17, 2025
Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical ImplicationsYuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 11, 2017
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophreniaTakahiro Sannohe, Tohru Ohnuma, Masayoshi Takeuchi, et al.
Pageof 4